Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Safer prescribing, older people/dementia
Schizoaffective disorder, atrial fibrillation patients
Schizophrenia treatment/prevention for tardive dyskinesia Omega-3 fatty acid (fish oils) in schizophrenia
Schizophrenia
Second-generation classification equivalent doses maximum doses adverse effects diabetes, antipsychotic-related long-acting injectable antipsychotics minimum effective doses
Second-generation antidepressants
Second-generation antipsychotics - approximate equivalent doses
Sedation alcohol effects medication-induced Relative adverse effects - a rough guide management over-sedation switching antipsychotics
Sedatives antihistamines not recommended for behavioural and psychological symptoms of dementia respiratory depression role in death from opioid agonists overdose in pregnancy use in patients with hepatic impairment
Sedatives in hepatic impairment
Seizures drug risks for people withq11.2 deletion syndrome,820, 821-822 psychotropic drug risks in people with epilepsy antiretrovirals management severe alcohol withdrawal
Selected clinical features and risks in people with 22q11.2 deletion syndrome.
Selective serotonin reuptake inhibitors Anxiety disorders in children and adolescents Obsessive compulsive disorder (OCD) and body dysmorphic disorder (BDD) in children and adolescents Depression in children and adolescents
selective serotonin reuptake inhibitors (SSRIs) anxiety spectrum disorders atrial fibrillation patients bleeding risks gynaecological and obstetric hemorrhage mechanisms risk factors adverse effects relative to other antidepressants arrhythmia risk bipolar depression gastrointestinal intracranial/intracerebral hemorrhage post stroke depression surgical and postoperative
selective serotonin reuptake inhibitors (SSRIs) (contâ™d) cardiac effects increased free plasma levels in hepatic impairment panic disorder post stroke depression use in children and adolescents gastrointestinal effects in pregnancy platelet effects sexual dysfunction
Serotonergic antidepressants, treatment of sexual dysfunction
serotonin-noradrenaline reuptake inhibitors (SNRIs) hyperprolactinaemia induction in pregnancy use in children and adolescents anxiety spectrum disorders hyponatraemia induction pharmacokinetic drug interactions
Serotonin syndrome switching antidepressants renal impairment
Sertraline bulimia nervosa/binge eating disorder in pregnancy Relative adverse effects - a rough guide Alternatives to clozapine Equivalent doses Quick reference for licensed maximum doses use in patients with hepatic impairment
Severe alcohol dependence
Severe alcohol withdrawal
Sexual adverse effects of antipsychotics
Sexual drive reduction by hormone implants
Sexual dysfunction effects of antipsychotics selective serotonin reuptake inhibitors antidepressants management of antidepressant effects treatment
Short Alcohol Withdrawal Scale (SAWS)
Site of administration of intramuscular injections
Skin diseases, and antipsychotics
Sleep disturbance managing behavioural and psychological symptoms of dementia autism spectrum disorder use of melatonin
Sleep disturbance/insomnia treatment, children and adolescents Autism spectrum disorder (ASD) in children and adolescents Doses of commonly used psychotropic drugs in children and adolescents Bipolar disorder in children and adolescents Melatonin in the treatment of insomnia in children and adolescents
Sleep disturbance in autism spectrum disorder